honokiol has been researched along with Chagas Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caballero, EP; Corral, RS; Mariz-Ponte, N; Rigazio, CS; Santamaría, MH | 1 |
1 other study(ies) available for honokiol and Chagas Disease
| Article | Year |
|---|---|
Honokiol attenuates oxidative stress-dependent heart dysfunction in chronic Chagas disease by targeting AMPK / NFE2L2 / SIRT3 signaling pathway.
Topics: AMP-Activated Protein Kinases; Biphenyl Compounds; Chagas Disease; Humans; Lignans; NF-E2-Related Factor 2; Oxidative Stress; Signal Transduction; Sirtuin 3 | 2020 |